Preclinical pharmacology and toxicology studies
Ended Definitive Contract Awarded Last action
- Contract number
- HHSN261200433004C
- Awardee
-
IIT Research Institute UEI DGBUFQYMKWB5
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $7,180,774
Award facts
- Contract value 21% obligated
-
- $29,565,085.15 Current, with exercised options
- $33,483,214.15 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- Not on record
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 8 offers
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Chicago, IL 60616, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$1 | |
| Other Administrative Action | $245,283 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $336,571 | |
| Supplemental Agreement for work within scope | $313,429 | |
| Funding Only Action | $1,357,588 | |
| Funding Only Action | $30,541 | |
| Funding Only Action | $1,300,000 | |
| Funding Only Action | $1,230,000 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $1,206,891 | |
| Original award | $1,160,472 |
Show all 14
About this award
This federal contract award, valued at $33,483,214.15, was issued by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to the IIT Research Institute (IITRI), a non-profit contract research organization. The contract is for preclinical pharmacology and toxicology studies to support the development of small molecule, biologic, and RNA therapeutic candidates across various disease areas.
IITRI has extensive experience providing these services to federal agencies, and holds several significant indefinite delivery/indefinite quantity (IDIQ) contract vehicles with agencies like the National Institute of Allergy and Infectious Diseases, National Center for Advancing Translational Sciences, and National Institute of Neurological Disorders and Stroke. These IDIQ contracts enable federal agencies to efficiently access IITRI's preclinical research capabilities on an as-needed basis, supporting critical drug development efforts. This particular award does not have a set-aside designation.
Quick answers
Who was awarded contract HHSN261200433004C?
HHSN261200433004C was awarded to IIT Research Institute by National Cancer Institute (National Institutes of Health) on April 30, 2004.
How much is contract HHSN261200433004C worth?
The government has obligated $7,180,774 on HHSN261200433004C. Its current value, with exercised options, is $29,565,085. Its potential value, with all options, is $33,483,214.
Was contract HHSN261200433004C competed?
The extent of competition for HHSN261200433004C was full and open competition. The government received 8 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award